Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucocutaneous Lymph Node Syndrome | 28 | 2023 | 535 | 6.030 |
Why?
|
Coronary Aneurysm | 16 | 2023 | 231 | 4.470 |
Why?
|
Aortic Valve Stenosis | 18 | 2022 | 2066 | 2.770 |
Why?
|
Hypoplastic Left Heart Syndrome | 11 | 2022 | 595 | 2.570 |
Why?
|
Fetal Heart | 9 | 2022 | 283 | 2.530 |
Why?
|
Systemic Inflammatory Response Syndrome | 15 | 2023 | 620 | 2.500 |
Why?
|
Immunoglobulins, Intravenous | 11 | 2022 | 660 | 2.170 |
Why?
|
Fetal Diseases | 8 | 2020 | 912 | 1.910 |
Why?
|
Echocardiography | 23 | 2021 | 4958 | 1.880 |
Why?
|
Fetal Therapies | 4 | 2020 | 102 | 1.590 |
Why?
|
Ultrasonography, Prenatal | 16 | 2020 | 1744 | 1.290 |
Why?
|
Pulmonary Valve | 4 | 2024 | 429 | 1.160 |
Why?
|
Ventricular Remodeling | 4 | 2018 | 1249 | 1.130 |
Why?
|
Diastole | 6 | 2016 | 788 | 1.110 |
Why?
|
Heart Defects, Congenital | 15 | 2023 | 4730 | 1.050 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2021 | 2129 | 0.910 |
Why?
|
Cardiac Surgical Procedures | 8 | 2024 | 3633 | 0.840 |
Why?
|
Echocardiography, Doppler | 7 | 2019 | 901 | 0.770 |
Why?
|
Thermodilution | 1 | 2021 | 51 | 0.750 |
Why?
|
Atrioventricular Block | 2 | 2020 | 121 | 0.750 |
Why?
|
Transposition of Great Vessels | 6 | 2020 | 589 | 0.730 |
Why?
|
Ductus Arteriosus, Patent | 4 | 2023 | 220 | 0.690 |
Why?
|
Heart Diseases | 6 | 2021 | 2799 | 0.680 |
Why?
|
Infant | 42 | 2024 | 35825 | 0.660 |
Why?
|
Chest Pain | 4 | 2017 | 1105 | 0.660 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1796 | 0.640 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2020 | 153 | 0.620 |
Why?
|
Gestational Age | 13 | 2022 | 3557 | 0.620 |
Why?
|
Critical Pathways | 5 | 2015 | 473 | 0.620 |
Why?
|
Decision Trees | 1 | 2020 | 505 | 0.610 |
Why?
|
Troponin | 2 | 2021 | 516 | 0.610 |
Why?
|
Hemodynamics | 5 | 2022 | 4184 | 0.600 |
Why?
|
Pulmonary Artery | 5 | 2020 | 1928 | 0.590 |
Why?
|
Myocarditis | 2 | 2022 | 767 | 0.580 |
Why?
|
Aorta, Thoracic | 4 | 2023 | 1075 | 0.570 |
Why?
|
Tetralogy of Fallot | 3 | 2024 | 634 | 0.570 |
Why?
|
Retrospective Studies | 53 | 2024 | 79726 | 0.570 |
Why?
|
Child | 54 | 2023 | 79405 | 0.560 |
Why?
|
Coronary Vessels | 5 | 2021 | 3115 | 0.530 |
Why?
|
Ventricular Function, Left | 7 | 2023 | 3844 | 0.530 |
Why?
|
Hydrops Fetalis | 1 | 2016 | 109 | 0.520 |
Why?
|
Immunologic Factors | 4 | 2021 | 1580 | 0.510 |
Why?
|
Vena Cava, Superior | 1 | 2016 | 197 | 0.500 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1867 | 0.480 |
Why?
|
Disease Management | 5 | 2020 | 2484 | 0.480 |
Why?
|
Fetus | 5 | 2022 | 1887 | 0.460 |
Why?
|
Heart Ventricles | 7 | 2020 | 3810 | 0.460 |
Why?
|
Fever | 2 | 2023 | 1613 | 0.460 |
Why?
|
Aortic Valve Insufficiency | 4 | 2022 | 584 | 0.450 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2016 | 821 | 0.440 |
Why?
|
Patient Care Management | 3 | 2011 | 299 | 0.430 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2016 | 366 | 0.420 |
Why?
|
Coronary Circulation | 2 | 2018 | 1579 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.420 |
Why?
|
Rheumatology | 4 | 2022 | 608 | 0.420 |
Why?
|
Child, Preschool | 30 | 2023 | 41845 | 0.420 |
Why?
|
Health Resources | 3 | 2017 | 923 | 0.420 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.410 |
Why?
|
Heart Septal Defects | 2 | 2024 | 191 | 0.410 |
Why?
|
Pregnancy | 23 | 2022 | 29548 | 0.410 |
Why?
|
Treatment Outcome | 27 | 2024 | 64563 | 0.400 |
Why?
|
Humans | 114 | 2024 | 755692 | 0.390 |
Why?
|
Infant, Newborn | 21 | 2023 | 26033 | 0.370 |
Why?
|
Female | 71 | 2022 | 387992 | 0.360 |
Why?
|
Heart Valve Diseases | 2 | 2022 | 1049 | 0.360 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1697 | 0.360 |
Why?
|
Syncope | 1 | 2013 | 427 | 0.350 |
Why?
|
Fontan Procedure | 2 | 2018 | 793 | 0.340 |
Why?
|
Immunosuppressive Agents | 3 | 2022 | 4093 | 0.330 |
Why?
|
Male | 63 | 2022 | 356614 | 0.330 |
Why?
|
Tachycardia, Supraventricular | 2 | 2022 | 273 | 0.320 |
Why?
|
Tracheobronchomalacia | 2 | 2021 | 131 | 0.320 |
Why?
|
Norwood Procedures | 2 | 2022 | 194 | 0.310 |
Why?
|
Juxtaglomerular Apparatus | 1 | 2007 | 15 | 0.300 |
Why?
|
Adolescent | 31 | 2022 | 87237 | 0.290 |
Why?
|
Follow-Up Studies | 15 | 2022 | 39181 | 0.280 |
Why?
|
Cardiac Output | 2 | 2021 | 835 | 0.280 |
Why?
|
Cardiac Imaging Techniques | 2 | 2021 | 275 | 0.270 |
Why?
|
Risk Factors | 17 | 2022 | 73895 | 0.260 |
Why?
|
Aorta | 4 | 2023 | 2037 | 0.260 |
Why?
|
Peptide Fragments | 1 | 2018 | 5086 | 0.250 |
Why?
|
Cardiology Service, Hospital | 3 | 2011 | 241 | 0.240 |
Why?
|
Aortic Valve | 6 | 2022 | 1992 | 0.240 |
Why?
|
Heart | 3 | 2021 | 4393 | 0.230 |
Why?
|
Hospital Costs | 1 | 2010 | 976 | 0.230 |
Why?
|
Pandemics | 2 | 2020 | 8570 | 0.220 |
Why?
|
Hospitalization | 3 | 2022 | 10683 | 0.220 |
Why?
|
Thrombosis | 4 | 2020 | 3032 | 0.210 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 298 | 0.210 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6625 | 0.200 |
Why?
|
Warfarin | 3 | 2021 | 1513 | 0.200 |
Why?
|
Predictive Value of Tests | 6 | 2022 | 15215 | 0.200 |
Why?
|
Bronchomalacia | 1 | 2021 | 13 | 0.190 |
Why?
|
Aortic Coarctation | 1 | 2023 | 285 | 0.190 |
Why?
|
Boston | 8 | 2021 | 9259 | 0.180 |
Why?
|
Pregnancy Outcome | 5 | 2018 | 2869 | 0.180 |
Why?
|
Hospitals, Pediatric | 5 | 2018 | 1847 | 0.180 |
Why?
|
Bronchial Diseases | 1 | 2021 | 151 | 0.180 |
Why?
|
Length of Stay | 3 | 2021 | 6429 | 0.170 |
Why?
|
Immunomodulation | 2 | 2021 | 544 | 0.170 |
Why?
|
Blood Circulation | 1 | 2021 | 248 | 0.170 |
Why?
|
Heart Rate, Fetal | 1 | 2020 | 75 | 0.170 |
Why?
|
Evidence-Based Medicine | 6 | 2022 | 3686 | 0.170 |
Why?
|
Program Evaluation | 4 | 2017 | 2473 | 0.160 |
Why?
|
Truncus Arteriosus | 1 | 2019 | 22 | 0.160 |
Why?
|
Disease Progression | 6 | 2021 | 13434 | 0.160 |
Why?
|
Aortic Arch Syndromes | 1 | 2019 | 19 | 0.160 |
Why?
|
Guideline Adherence | 4 | 2021 | 2280 | 0.160 |
Why?
|
Pulmonary Atresia | 1 | 2020 | 161 | 0.160 |
Why?
|
Stroke Volume | 6 | 2023 | 5471 | 0.160 |
Why?
|
Thrombophilia | 1 | 2021 | 307 | 0.160 |
Why?
|
Heart Transplantation | 3 | 2020 | 3076 | 0.160 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 1106 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 4 | 2018 | 6523 | 0.160 |
Why?
|
Atrial Flutter | 1 | 2020 | 258 | 0.160 |
Why?
|
Case-Control Studies | 7 | 2021 | 21902 | 0.150 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2022 | 353 | 0.150 |
Why?
|
Atrial Function | 1 | 2018 | 99 | 0.150 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2020 | 345 | 0.150 |
Why?
|
Chemoprevention | 1 | 2020 | 326 | 0.150 |
Why?
|
Management Audit | 1 | 2017 | 23 | 0.150 |
Why?
|
Young Adult | 16 | 2022 | 58040 | 0.140 |
Why?
|
Prognosis | 8 | 2021 | 29423 | 0.140 |
Why?
|
Ventricular Septum | 1 | 2017 | 76 | 0.140 |
Why?
|
Coronary Vessel Anomalies | 1 | 2020 | 317 | 0.140 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15659 | 0.140 |
Why?
|
Airway Management | 1 | 2020 | 309 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 458 | 0.140 |
Why?
|
Professional-Family Relations | 1 | 2021 | 489 | 0.140 |
Why?
|
Pulsatile Flow | 1 | 2017 | 320 | 0.140 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2017 | 152 | 0.140 |
Why?
|
Reoperation | 4 | 2024 | 4282 | 0.130 |
Why?
|
Pediatrics | 1 | 2011 | 3582 | 0.130 |
Why?
|
Electrocardiography | 3 | 2021 | 6387 | 0.130 |
Why?
|
Remission, Spontaneous | 1 | 2016 | 382 | 0.130 |
Why?
|
Amniotic Fluid | 1 | 2018 | 378 | 0.130 |
Why?
|
Nervous System Malformations | 1 | 2017 | 243 | 0.130 |
Why?
|
Risk Assessment | 8 | 2020 | 23958 | 0.130 |
Why?
|
Leukoencephalopathies | 1 | 2018 | 249 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2015 | 15589 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2020 | 780 | 0.130 |
Why?
|
Steroids | 1 | 2020 | 923 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1153 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2021 | 19999 | 0.120 |
Why?
|
Anticoagulants | 6 | 2021 | 4864 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 9 | 2022 | 36056 | 0.120 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2018 | 468 | 0.120 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2219 | 0.120 |
Why?
|
Saphenous Vein | 1 | 2018 | 537 | 0.120 |
Why?
|
Aspirin | 3 | 2021 | 3346 | 0.120 |
Why?
|
Pyridones | 1 | 2020 | 782 | 0.120 |
Why?
|
Glucocorticoids | 2 | 2021 | 2147 | 0.120 |
Why?
|
Registries | 5 | 2023 | 8402 | 0.120 |
Why?
|
Endocardial Fibroelastosis | 1 | 2014 | 56 | 0.110 |
Why?
|
Microcephaly | 1 | 2017 | 422 | 0.110 |
Why?
|
Systole | 1 | 2016 | 948 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6480 | 0.110 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 1418 | 0.110 |
Why?
|
Coronary Occlusion | 1 | 2016 | 308 | 0.110 |
Why?
|
Likelihood Functions | 1 | 2016 | 987 | 0.110 |
Why?
|
Time Factors | 8 | 2020 | 39973 | 0.110 |
Why?
|
Vascular Surgical Procedures | 2 | 2020 | 1460 | 0.110 |
Why?
|
Exercise Test | 2 | 2011 | 2121 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2011 | 927 | 0.110 |
Why?
|
Antirheumatic Agents | 2 | 2021 | 1369 | 0.110 |
Why?
|
Blood Flow Velocity | 2 | 2016 | 1372 | 0.100 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2098 | 0.100 |
Why?
|
United States | 11 | 2022 | 71903 | 0.100 |
Why?
|
Bradycardia | 1 | 2014 | 298 | 0.100 |
Why?
|
Heart Atria | 1 | 2018 | 1344 | 0.100 |
Why?
|
Palliative Care | 3 | 2018 | 3597 | 0.100 |
Why?
|
Logistic Models | 4 | 2021 | 13315 | 0.100 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3812 | 0.100 |
Why?
|
Ventricular Pressure | 1 | 2012 | 204 | 0.100 |
Why?
|
Coronary Stenosis | 1 | 2017 | 819 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2271 | 0.100 |
Why?
|
Needs Assessment | 1 | 2017 | 1142 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1926 | 0.090 |
Why?
|
Brain | 5 | 2022 | 26709 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1474 | 0.090 |
Why?
|
Adult | 19 | 2022 | 218083 | 0.090 |
Why?
|
Kidney Neoplasms | 1 | 2007 | 4305 | 0.090 |
Why?
|
Social Class | 1 | 2019 | 1996 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5180 | 0.090 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12933 | 0.090 |
Why?
|
Program Development | 3 | 2011 | 1289 | 0.090 |
Why?
|
Massachusetts | 4 | 2021 | 8733 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 1983 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2932 | 0.080 |
Why?
|
Heart Arrest | 1 | 2019 | 1487 | 0.080 |
Why?
|
Echocardiography, Stress | 1 | 2010 | 135 | 0.080 |
Why?
|
Biomedical Research | 2 | 2015 | 3388 | 0.080 |
Why?
|
Preoperative Care | 1 | 2018 | 2249 | 0.080 |
Why?
|
Age Factors | 5 | 2021 | 18371 | 0.080 |
Why?
|
Cost Savings | 2 | 2013 | 916 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2019 | 4045 | 0.080 |
Why?
|
Blood Chemical Analysis | 1 | 2010 | 434 | 0.080 |
Why?
|
Practice Guidelines as Topic | 4 | 2013 | 7433 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2522 | 0.080 |
Why?
|
Quality Improvement | 4 | 2017 | 3826 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 2014 | 814 | 0.080 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2021 | 1014 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1834 | 0.070 |
Why?
|
Standard of Care | 1 | 2011 | 550 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20419 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2016 | 1292 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1806 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3708 | 0.070 |
Why?
|
Hypertension | 1 | 2007 | 8532 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2020 | 11876 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7786 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2269 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2778 | 0.070 |
Why?
|
Parents | 1 | 2021 | 3532 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2012 | 902 | 0.070 |
Why?
|
Prenatal Diagnosis | 3 | 2020 | 1270 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4256 | 0.070 |
Why?
|
Office Visits | 1 | 2010 | 592 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2017 | 2104 | 0.060 |
Why?
|
Catheterization | 1 | 2011 | 1431 | 0.060 |
Why?
|
Anastomosis, Surgical | 2 | 2020 | 985 | 0.060 |
Why?
|
Fetal Death | 2 | 2020 | 430 | 0.060 |
Why?
|
Cohort Studies | 5 | 2021 | 41111 | 0.060 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2010 | 568 | 0.060 |
Why?
|
Incidence | 4 | 2020 | 21258 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2636 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1426 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8014 | 0.060 |
Why?
|
Health Care Costs | 1 | 2017 | 3230 | 0.060 |
Why?
|
Radiography, Thoracic | 1 | 2010 | 1292 | 0.060 |
Why?
|
Blood Pressure Determination | 1 | 2007 | 637 | 0.060 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3829 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2019 | 5723 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12160 | 0.050 |
Why?
|
Prolapse | 1 | 2022 | 63 | 0.050 |
Why?
|
Renin-Angiotensin System | 1 | 2007 | 736 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2013 | 2176 | 0.050 |
Why?
|
Health Services Research | 1 | 2010 | 1811 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1633 | 0.050 |
Why?
|
Rare Diseases | 1 | 2007 | 618 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12504 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5161 | 0.050 |
Why?
|
Nephrectomy | 1 | 2007 | 1010 | 0.050 |
Why?
|
Algorithms | 3 | 2017 | 13958 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7776 | 0.050 |
Why?
|
Embolectomy | 1 | 2021 | 128 | 0.050 |
Why?
|
Ligation | 1 | 2021 | 449 | 0.050 |
Why?
|
Splints | 1 | 2021 | 107 | 0.050 |
Why?
|
Antithrombin III | 1 | 2020 | 129 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 321 | 0.040 |
Why?
|
Macrophage Activation Syndrome | 1 | 2020 | 123 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2022 | 407 | 0.040 |
Why?
|
Thrombelastography | 1 | 2021 | 179 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 616 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13205 | 0.040 |
Why?
|
Child, Hospitalized | 1 | 2021 | 180 | 0.040 |
Why?
|
Infant Mortality | 2 | 2014 | 750 | 0.040 |
Why?
|
Shock | 1 | 2021 | 318 | 0.040 |
Why?
|
Infant, Premature | 2 | 2021 | 2081 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 419 | 0.040 |
Why?
|
Health Personnel | 1 | 2011 | 3280 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 460 | 0.040 |
Why?
|
Delphi Technique | 1 | 2021 | 804 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2019 | 376 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 888 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2021 | 3176 | 0.040 |
Why?
|
Polytetrafluoroethylene | 1 | 2018 | 245 | 0.040 |
Why?
|
Antithrombins | 1 | 2020 | 313 | 0.040 |
Why?
|
Gadolinium | 1 | 2022 | 954 | 0.040 |
Why?
|
Pericardium | 1 | 2021 | 675 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2021 | 844 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 3947 | 0.030 |
Why?
|
American Heart Association | 1 | 2021 | 1081 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 584 | 0.030 |
Why?
|
Fibrinogen | 1 | 2020 | 885 | 0.030 |
Why?
|
Advisory Committees | 1 | 2021 | 788 | 0.030 |
Why?
|
Hemorrhage | 2 | 2020 | 3594 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2019 | 735 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 919 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2020 | 599 | 0.030 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2019 | 491 | 0.030 |
Why?
|
Cattle | 1 | 2021 | 3846 | 0.030 |
Why?
|
Family Health | 1 | 2021 | 1261 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2017 | 386 | 0.030 |
Why?
|
California | 1 | 2019 | 1401 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1163 | 0.030 |
Why?
|
Fetal Development | 1 | 2020 | 767 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2010 | 4364 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2121 | 0.030 |
Why?
|
Fetal Mortality | 1 | 2014 | 19 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2020 | 898 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1437 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2019 | 836 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2020 | 1188 | 0.030 |
Why?
|
Health Education | 1 | 2021 | 1050 | 0.030 |
Why?
|
Mitral Valve | 1 | 2022 | 1483 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14393 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1903 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11026 | 0.030 |
Why?
|
Prospective Studies | 4 | 2020 | 54015 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2117 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2018 | 1515 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15752 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2248 | 0.030 |
Why?
|
Heparin | 1 | 2020 | 1653 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2847 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3757 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2019 | 1690 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6362 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2018 | 1023 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15596 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3059 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7228 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2499 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3203 | 0.020 |
Why?
|
Hospice Care | 1 | 2017 | 692 | 0.020 |
Why?
|
Child Development | 1 | 2022 | 2269 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3763 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2166 | 0.020 |
Why?
|
Edema | 1 | 2014 | 771 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3452 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2031 | 0.020 |
Why?
|
Myocardium | 1 | 2022 | 4683 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8558 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5863 | 0.020 |
Why?
|
Contrast Media | 1 | 2022 | 5305 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7261 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2019 | 2194 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2018 | 2715 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2010 | 428 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2018 | 1416 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2013 | 710 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3662 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2275 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2684 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2020 | 3345 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2010 | 430 | 0.020 |
Why?
|
Comprehension | 1 | 2011 | 616 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25705 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10184 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2607 | 0.010 |
Why?
|
Delivery of Health Care | 2 | 2013 | 5296 | 0.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1274 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7947 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10254 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2008 | 1250 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10717 | 0.010 |
Why?
|
Patient Admission | 1 | 2008 | 1383 | 0.010 |
Why?
|
Health Policy | 1 | 2013 | 2666 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10535 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5499 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12791 | 0.010 |
Why?
|
Animals | 1 | 2021 | 167068 | 0.010 |
Why?
|
Middle Aged | 1 | 2011 | 218183 | 0.000 |
Why?
|